Psychoeducation for AlloHCT Caregivers
- Conditions
- CancerCopingCaregiversStem Cell TransplantPsychoeduction
- Registration Number
- NCT07116018
- Lead Sponsor
- University Health Network, Toronto
- Brief Summary
Background: Caregivers of patients undergoing allogeneic hematopoietic cell transplantation (alloHCT) for hematological malignancies face significant challenges that can impact their well-being. This study aims to evaluate the feasibility and acceptability of an adapted psychoeducational intervention(PEI) designed to support these caregivers.
Methods: This study will recruit caregivers of alloHCT patients. Participants will be enrolled during pre-transplant clinic visits, typically 2-4 weeks before the scheduled transplant. The intervention consists of eight sessions over 12 weeks, delivered via Microsoft Teams by a nurse facilitator. In the adapted PEI, participants will learn stress management, coping strategies, energy management, goal-setting, communication skills, and support resource access through interactive exercises. Data Collection: Participants will complete questionnaires at three time points: pre-intervention, one month post-transplant, and three months post-transplant. The final assessment will include additional questions about feasibility, acceptability and the initial efficacy of the adapted PEI.
Outcomes: The primary outcomes will be the feasibility and acceptability of the adapted psychoeducational intervention (PEI). Secondary outcomes will include initial efficacy of the adapted PEI on caregiver outcomes such as depression, anxiety, satisfaction with caregiving and quality of life.
Significance: This research aims to assess the feasibility, acceptability and initial efficacy of implementing the adapted PEI for alloHCT caregivers. If found feasible and acceptable, this intervention could potentially improve caregivers' ability to manage caregiving stressors and pave the way for larger-scale randomized studies and implementation.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 22
- Must be caregiver for an adult patient diagnosed with hematological malignancy who is scheduled to receive allogeneic stem cell transplant.
- Are recruited and consented to participate in the caregiver study during the patient's pre-transplant screening phase for allogeneic stem cell transplant.
- Will provide care for the patient from the day of allogeneic stem cell transplant up to 100 days post- transplant.
- Are willing to begin the study intervention no earlier than 0-day post-transplant and not later than 2-weeks post-transplant.
- Less than 18 years of age
- Non-English speaking
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Feasibility of Intervention Measure (FIM) 3 months The Feasibility of Intervention Measure (FIM) revised to evaluated the psychoeducation program comprises 4-items regarding the respondent's perceptions of the feasibility of the intervention. Responses range from 1 (completely disagree) to 5 (completely agree). Scale value is computed by averaging responses and ranges from 1-5. Higher values indicate greater feasibility of the intervention.
Intervention Appropriateness Measure (IAM) 3 months The Intervention Appropriate Measure (IAM) revised to evaluated the psychoeducation program comprises 4-items regarding the respondent's perceptions of the appropriateness of the intervention. Responses range from 1 (completely disagree) to 5 (completely agree). Scale value is computed by averaging responses and ranges from 1-5. Higher values indicate greater appropriateness of the intervention.
Acceptability of Intervention Measure (AIM) 3 months The Acceptability of Intervention Measure (AIM) revised to evaluated the psychoeducation program comprises 4-items regarding the respondent's perceptions of the acceptability of the intervention. Responses range from 1 (completely disagree) to 5 (completely agree). Scale value is computed by averaging responses and ranges from 1-5. Higher values indicate greater acceptability of the intervention.
- Secondary Outcome Measures
Name Time Method Perceived Stress Baseline, 1 month, 3 months Perceived Stress Scale (PSS)
Depression Baseline, 1 month, 3 months Centre for Epidemiological Studies- Depression (CES-D) scale
Caregiver Quality of Life Baseline, 1 month, 3 months Caregiver Quality of Life Index- Cancer Scale
Satisfaction with Life Baseline, 1 month, 3 months Satisfaction with Life Scale
Anxiety Baseline, 1 month, 3 months State-Trait Anxiety Inventory (STAI)
Trial Locations
- Locations (1)
Princess Margaret Cancer Centre, University Health Network
🇨🇦Toronto, Ontario, Canada
Princess Margaret Cancer Centre, University Health Network🇨🇦Toronto, Ontario, CanadaSamantha Mayo, RN, PhDContact437-218-0860samantha.mayo@uhn.caGrace Kusi, RN, PhD candidateContactgrace.kusi@uhn.ca